Entheogen is a term coined in 1979 by scholars Carl Ruck, R. Gordon Wasson, Jonathan Ott, and colleagues to describe psychoactive substances used in religious, spiritual, or shamanic contexts to induce states of consciousness interpreted as contact with the sacred, the divine, or transcendent reality. The word is derived from the Greek entheos ("having the god within") and genesthai ("to generate") — literally, "that which generates the divine within." It was proposed as a more precise and less culturally loaded alternative to terms like "psychedelic," "hallucinogen," or "intoxicant," which carry connotations of Western recreational drug culture.
Entheogens include a wide range of substance classes: classical serotonergic psychedelics (psilocybin mushrooms, LSD, DMT, mescaline), dissociatives (ketamine, used in some contemporary spiritual practices), deliriants (datura, fly agaric), cannabis, and various plant preparations (ayahuasca, San Pedro cactus, iboga, morning glory). What unites them is not chemistry but context: the intention, set, setting, and cultural frameworks within which they are used. A substance that serves as an entheogen in a curated indigenous ceremony is not categorically different from the same substance used recreationally — but the context transforms the meaning and often the nature of the experience.
The concept of entheogens has been enormously influential in the study of religion, anthropology, and the pharmacology of consciousness. It has also been important in contemporary psychedelic therapy — the therapeutic framework explicitly imports entheogenic elements (intention, ceremony, music, relational support) into clinical settings, recognizing that the context of use profoundly shapes therapeutic outcomes.
Safety at a Glance
High Risk- Entheogenic Context as Harm Reduction
- Preparation: Dietary restrictions, periods of abstinence, intention-setting
- Toxicity: Context-Dependent Risk The risk profile of entheogens cannot be generalized across the category — different substance...
- Overdose risk: Limited specific overdose data is available for Entheogen. In the absence of compound-specific in...
If someone is in crisis, call 911 or Poison Control: 1-800-222-1222
Duration
No duration data available.
How It Feels
The term entheogen, meaning "generating the divine within," refers to psychoactive substances used in spiritual or religious contexts to facilitate mystical experience, communion with the sacred, or personal transformation. While the term overlaps substantially with "psychedelic," it emphasizes intention and context rather than pharmacology.
The entheogenic experience, at its core, involves a sense of contact with something larger than the individual self, whether understood as God, nature, the unconscious, or a universal consciousness. This experience is characterized by feelings of unity, sacredness, noetic quality (the sense that what is experienced is deeply true), and ineffability (the impossibility of adequately describing the experience in words). It may be accompanied by visions, emotional catharsis, dissolution of the ordinary sense of self, and a lasting sense of meaning and purpose.
The substances classified as entheogens, including ayahuasca, psilocybin mushrooms, peyote, and DMT, produce these experiences through the same pharmacological mechanisms as recreational psychedelics. The distinction lies in the ceremonial, intentional, and often communal context in which they are used.
Subjective Effects
The effects listed below are based on the Subjective Effect Index (SEI), an open research literature based on anecdotal reports and personal analyses. They should be viewed with a healthy degree of skepticism. These effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects.
Physical Effects
Physical(1)
- Sedation— A state of deep physical and mental calming that manifests as a progressive desire to remain still, ...
Cognitive & Perceptual Effects
Cognitive(3)
- Catharsis— A powerful emotional release and cleansing involving the surfacing, processing, and resolution of de...
- Paranoia— Irrational suspicion and belief that others are watching, plotting against, or intending harm toward...
- Psychosis— Psychosis is a serious psychiatric state involving a fundamental break from consensus reality — char...
Transpersonal(1)
- Ego death— A profound dissolution of the sense of self in which personal identity, memories, and the boundary b...
Pharmacology
No Single Pharmacology — Context-Defined Category
Entheogens are defined by use context rather than mechanism of action. The class includes substances with radically different pharmacological mechanisms:
Serotonergic Psychedelics (Most Common Class) 5-HT2A agonists: psilocin, LSD, DMT, mescaline, 5-MeO-DMT. These substances disrupt normal thalamocortical filtering of sensory information, increase neural entropy, and produce the expanded, destabilized, or transcendent states that characterize classic entheogenic experiences. The default mode network (DMN) — associated with the narrative sense of self — is particularly affected, correlating with experiences of ego dissolution and self-transcendence that are highly valued in spiritual contexts.
Dissociatives NMDA antagonists: ketamine, DXM (in some traditions). These produce dissociation of awareness from sensory input, out-of-body experiences, and encounters with non-ordinary realities through mechanisms distinct from serotonergic psychedelics. Ketamine-assisted psychotherapy increasingly incorporates entheogenic framing.
Muscimol/Ibotenic Acid (Amanita muscaria) GABA-A positive allosteric modulation (muscimol) combined with NMDA agonism (ibotenic acid) produces a qualitatively distinct altered state — sedating, oneiric, and dissociative — different from classical psychedelics.
Cannabis CB1 receptor agonism; used entheogens in many traditions (Hinduism, Rastafarianism, Scythian practices).
Ibogaine Complex multi-receptor pharmacology including sigma-1 agonism, NMDA antagonism, kappa-opioid agonism, and monoamine reuptake inhibition. Produces an extraordinarily long, visionary experience used in the Bwiti tradition of Central Africa and increasingly in addiction medicine.
Interactions
No documented interactions.
History
Coining the Term
The word "entheogen" was proposed in 1979 in a paper by ethnobotanist Richard Evans Schultes, classicist Carl Ruck, ethnomycologist R. Gordon Wasson, and scholars Jonathan Ott and Jeremy Bigwood, published in the Journal of Psychedelic Drugs. The paper argued that existing terminology — "psychedelic" (coined by Humphry Osmond in 1957) and "hallucinogen" — inadequately captured the sacred and transformative character of these substances in traditional contexts. "Psychedelic" had become irrevocably associated with 1960s recreational counterculture; "hallucinogen" pathologized the experience. "Entheogen" offered an academically neutral term that foregrounded spiritual context.
Ancient Entheogenic Use
Scholarly debate continues about the role of psychoactive plants in the origins of religion and human culture. Key proposed historical entheogens include:
- Soma: The Vedic ritual drink described in the Rigveda (1500–1200 BCE), possibly identified with Amanita muscaria or Ephedra species
- Kykeon: The ritual drink of the Eleusinian Mysteries in ancient Greece, possibly containing ergot-derived compounds structurally related to LSD, as argued by Wasson, Hofmann, and Ruck in The Road to Eleusis (1978)
- Teonanacatl: Psilocybin mushrooms used by Aztec priests in divinatory and healing ceremonies
- Huachuma (San Pedro) and ayahuasca: Used in Andean and Amazonian traditions for thousands of years
Contemporary Relevance
The entheogen concept became increasingly mainstream as academic study of psychedelic-assisted therapy accelerated in the 21st century. The MAPS (Multidisciplinary Association for Psychedelic Studies) clinical trials for PTSD treatment with MDMA, and psilocybin trials at Johns Hopkins and NYU, all incorporate entheogenic elements — intention, supportive presence, music — into their protocols, recognizing the empirical significance of context that the entheogen literature documented.
Harm Reduction
Entheogenic Context as Harm Reduction
The concept of set and setting — formalized in the psychedelic research context by Timothy Leary and elaborated by subsequent researchers — is essentially a codification of traditional entheogenic harm reduction principles. Indigenous traditions have developed elaborate practices for minimizing harm and maximizing benefit from powerful substances:
- Preparation: Dietary restrictions, periods of abstinence, intention-setting
- Expert guidance: The presence of an experienced guide who has undergone the same experience and knows the psychological landscape
- Ritual container: Music, prayer, and ceremonial structure that provide orientation during the experience
- Community support: The experience is held within a community, reducing isolation
- Integration: Post-experience processing and support
These elements represent accumulated practical knowledge about human vulnerability and resilience in the context of extreme altered states.
Contemporary Integration Practices
The renaissance in psychedelic therapy has formalized entheogenic harm reduction into evidence-based therapeutic protocols. Key elements include: psychological screening (exclusion of psychosis-predisposed individuals), preparation sessions, trained therapist accompaniment, music, and follow-up integration therapy.
Research Substances vs Traditional Preparations
Users approaching entheogens through research chemical or uncharacterized supply chains lack the quality control, dosing consistency, and cultural context of traditional preparations. Standard psychedelic harm reduction applies: reagent testing, dose calibration, trusted companionship, and thoughtful preparation.
Avoiding Predatory Practitioners
The commercialization of ayahuasca tourism and ceremony has created contexts where vulnerable participants encounter unscreened leaders, inadequate safety protocols, and exploitation. Seek ceremonial contexts with documented safety protocols, medical screening, and clear consent frameworks.
Toxicity & Safety
Context-Dependent Risk
The risk profile of entheogens cannot be generalized across the category — different substance classes have radically different toxicity profiles. However, some cross-cutting considerations apply.
The Entheogenic Context as Risk Modifier
Anthropological and clinical evidence consistently suggests that the context of entheogen use is itself a significant determinant of outcomes. Indigenous ceremonial use, conducted by experienced practitioners with established frameworks, screening criteria, and integration support, has a notably different (generally more favorable) safety profile than unguided recreational use of the same substances.
Psychological Risks Across the Category
- Acute psychological crisis: Even in supportive settings, powerful altered states can produce overwhelming terror, paranoia, or psychotic-like experiences
- Precipitation of latent mental illness in predisposed individuals (particularly relevant for psychedelics and cannabis in those with family history of psychosis)
- Challenging integration: Difficult or destabilizing experiences may require psychological support to process constructively
Specific Class Risks
- Datura and tropane alkaloid plants (jimsonweed, angel's trumpet): Genuine life-threatening anticholinergic toxicity even at ritual doses; blindness, cardiac arrhythmia, death. Among the most genuinely dangerous substances in any entheogenic tradition.
- Ayahuasca: MAO inhibition from harmala alkaloids creates serious drug interaction risks; dietary restrictions and medication contraindications must be strictly observed
- Ibogaine: Significant cardiac toxicity risk (QT prolongation, ventricular arrhythmia); multiple deaths associated with cardiac complications. Medical screening is essential.
Ritual/Ceremonial Safety Considerations
Ayahuasca ceremonies in particular have been the subject of serious adverse event reporting — including sexual abuse by ceremonial leaders, fatalities from mixing with contraindicated medications, and psychological crises without adequate support.
Overdose Information
Limited specific overdose data is available for Entheogen. In the absence of compound-specific information, general principles apply:
If someone exhibits signs of medical distress after using Entheogen — difficulty breathing, severe confusion, seizures, chest pain, extremely elevated temperature, or loss of consciousness — treat it as a medical emergency. Call emergency services and be forthcoming about what was consumed. Medical professionals follow confidentiality protocols and their priority is saving lives.
Prevention remains the best approach: use the minimum effective dose, avoid combining with other substances, and always have a sober person present who can recognize signs of distress and call for help.
Tolerance
| Full | Unknown |
| Half | Unknown |
| Zero | Unknown |
Legal Status
The legal status of Entheogen varies by jurisdiction and is subject to change. This information is provided for educational purposes and may not reflect the most current legislation.
General patterns: Many psychoactive substances are controlled under national and international drug control frameworks, including the United Nations Single Convention on Narcotic Drugs (1961), the Convention on Psychotropic Substances (1971), and country-specific legislation such as the US Controlled Substances Act, UK Misuse of Drugs Act, and EU Framework Decisions.
Research chemicals and analogues: Novel psychoactive substances may be captured by analogue laws (e.g., the US Federal Analogue Act) or blanket bans on substance classes (e.g., the UK Psychoactive Substances Act 2016), even if the specific compound is not individually scheduled.
Important note: Possessing, distributing, or manufacturing controlled substances carries serious legal consequences in most jurisdictions. Legal status is not a reliable indicator of a substance's safety profile — some highly dangerous substances are legal, while some with favorable safety profiles are strictly controlled.
Users are strongly encouraged to research the specific legal status of Entheogen in their jurisdiction before any involvement with this substance.
Experience Reports (2)
Tips (5)
Research potential interactions before combining Entheogen with other substances. Drug interactions can be unpredictable and dangerous.
Keep a usage log for Entheogen including dose, time, effects, and side effects. This helps you identify patterns and prevent problematic escalation.
Entheogens used in ritual contexts are not inherently safer than recreational psychedelic use. Proper set, setting, dose measurement, and awareness of contraindications remain essential regardless of the spiritual framework you bring to the experience.
Reading Carl Jung's The Red Book or similar works on the unconscious before an entheogenic experience can profoundly shape the trip. Users report that having a framework for symbolic and archetypal thinking transforms ambiguous or nihilistic trips into deeply meaningful ones.
For those interested in long-term entheogenic practice, cultivating your own sacramental plants (mushrooms, cacti, ayahuasca vine) removes dependency on unreliable supply chains and creates a deeper personal relationship with the medicine.
Community Discussions (2)
See Also
References (2)
- Entheogen - TripSit Factsheet
TripSit factsheet for Entheogen
tripsit - Entheogen - Wikipedia
Wikipedia article on Entheogen
wikipedia